Skip to content

Pharmaceutical intermediate

7-Methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one

CAS 199327-61-2
8

Safety score · 0–100

Avoid

Derived from EU CosIng regulatory status, PubChem hazard data and published research. How we score.

A pharmaceutical synthesis intermediate related to kinase inhibitor drugs, not a legitimate cosmetic ingredient. Its presence in personal care products would not be appropriate under EU cosmetic rules.

Skin benefits

  • Pharmaceutical intermediate (kinase-inhibitor synthesis)
  • No cosmetic benefit

Known concerns

  • Pharmaceutical synthesis intermediate, not a cosmetic ingredient
  • Quinazolinone scaffold can be biologically active and is not safety-assessed for skin use
  • Should not be present in cosmetics in the EU
  • Potential reproductive and systemic toxicity by analogy to related kinase inhibitor intermediates

References

EU

EU CosIng database

European Commission cosmetic ingredient registry: regulatory status, restrictions, authorised functions.

Check your shelf

Find 7-Methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one in your products.

Scan any cosmetic product with LuxSense to see if it contains 7-Methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one and get a full ingredient breakdown with safety scores.

This profile is for educational purposes and does not constitute medical advice. Regulatory status and scientific understanding evolve, so always read the physical product label and consult a healthcare professional for personal concerns.